Gentian Diagnostics develops and manufactures in vitro diagnostic reagents using proprietary PETIA (particle-enhanced turbidimetric immunoassays) technology to convert existing biomarkers to automated, high-throughput analyzers.
Developer of indoor positioning technologies intended to position people, equipment, and smartphones accurately and reliably. The company's technology supports a range of applications including asset management, patient flow management, workflow management, infection control, nurse call, and environmental monitoring, enabling healthcare organizations to increase productivity, reduce costs, and make hospital operations more efficient.